TITLE:
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

CONDITION:
Hormone-Refractory Prostate Cancer

INTERVENTION:
YM598

SUMMARY:

      The purpose of this study is to determine if patients who take YM598 in addition to
      mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated
      with prostate cancer metastases in the bone.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Male
Age: 18 Years to N/A
Criteria:
NONE
